Clinical Trial

Virtual Therapeutics for MCI

Study acronym: VR-MCI
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated March 8, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Mild Cognitive Impairment (MCI) is a term used to describe the transitional stage that occurs between normal aging and the onset of dementia. Spatial disorientation is often considered a significant indicator for diagnosing dementia. Numerous studies have documented deficits in both the allocentric and egocentric spatial frames of reference, as well as difficulties in transitioning between them, in individuals with MCI. Rapid advances in computing technology have enabled researchers to conduct cognitive training and rehabilitation interventions with the assistance of technology. Therefore, the aim of the study is to use virtual therapeutics to train MCI spatial memory.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06079411
Lead Sponsor Istituto Auxologico Italiano
Collaborators: Istituto Superiore di Sanità, University of Turin, Italy
Conditions Mild Cognitive Impairment
Enrollment 36 participants
Start Date 2023-10-17
Primary Completion 2026-04 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-03-08